GleamWall
中文EN

ZBH ZIMMER BIOMET HOLDINGS, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1136869 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.0%
TTM net income YoY-4.7%
TTM EPS YoY-1.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR17.4%

Margins

Gross margin69.7%
Operating margin13.6%
Net margin9.0%
FCF margin19.2%
EBITDA margin26.5%

Returns

ROE6.0%
ROA3.3%
ROIC (approx.)5.1%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets45.9%
Debt / equity0.59x
Current ratio1.46x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.46x
Accruals ratio-4.8%
Payout ratio24.3%
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.06B$2.18B$2.09B$2.24B$2.00B$2.08B$1.91B$2.02B
Cost of revenue$594.50M$635.50M$576.20M$792.40M$559.30M$592.20M$549.80M$586.70M
Gross profit$1.47B$1.54B$1.51B$1.45B$1.44B$1.49B$1.36B$1.44B
R&D expense$105.90M$104.80M$103.40M$118.70M$115.90M$113.30M$110.60M$108.50M
SG&A expense$855.00M$899.30M$849.90M$872.30M$811.40M$814.80M$758.80M$746.90M
Operating income$307.60M$326.10M$373.20M$154.50M$351.30M$300.00M$292.30M$389.00M
Pretax income$230.10M$255.10M$301.30M$98.00M$279.20M$224.60M$229.00M$289.00M
Income tax$37.20M$55.50M$63.00M-$39.90M$48.00M$71.20M$46.50M$48.90M
Net income$191.60M$198.30M$238.10M$139.30M$230.90M$152.80M$182.00M$239.50M
EBITDA$589.60M$596.90M$643.20M$438.50M$634.90M$571.80M$546.70M$652.60M
EPS (basic)1.011.031.22—1.170.770.92—
EPS (diluted)1.001.031.22—1.160.770.91—
Dividends declared per share0.240.240.240.240.240.240.240.24
Weighted avg. shares (diluted)191.40M192.80M195.80M—198.80M198.30M199.70M—
Banking
Net interest income-$74.90M-$72.90M-$68.80M-$71.90M-$75.40M-$79.30M-$66.20M-$61.90M
Balance sheet
Cash & equivalents$399.90M$410.00M$424.20M$591.90M$1.29B$556.90M$1.38B$525.50M
Receivables$1.82B$1.77B$1.73B$1.70B$1.60B$1.61B$1.53B$1.48B
Inventory$2.37B$2.27B$2.25B$2.29B$2.48B$2.45B$2.24B$2.24B
Current assets$5.13B$5.10B$4.96B$5.12B$5.83B$5.05B$5.59B$4.67B
PP&E, net$2.31B$2.24B$2.21B$2.21B$2.19B$2.18B$2.06B$2.05B
Goodwill$10.34B$9.92B$9.93B$9.95B$9.70B$9.71B$8.99B$8.95B
Intangibles$4.63B$4.46B$4.55B$4.72B$4.74B$4.89B$4.47B$4.60B
Total assets$23.54B$22.80B$22.72B$23.09B$23.49B$22.87B$22.18B$21.37B
Current liabilities$3.50B$3.01B$2.86B$2.58B$2.40B$2.70B$2.29B$2.45B
Short-term debt$1.29B$1.20B$1.18B$587.10M$600.00M$820.00M$600.00M$863.00M
Long-term debt$6.22B$6.28B$6.30B$6.93B$7.51B$6.75B$6.58B$5.34B
Total debt$7.50B$7.48B$7.47B$7.52B$8.11B$7.57B$7.18B$6.20B
Total liabilities$10.81B$10.17B$10.04B$10.39B$10.72B$10.33B$9.78B$8.89B
Shareholders' equity$12.72B$12.62B$12.67B$12.70B$12.76B$12.53B$12.40B$12.47B
Net debt$7.10B$7.07B$7.05B$6.93B$6.82B$7.02B$5.79B$5.68B
Cash flow statement
Operating cash flow$560.00M$447.80M$359.40M$517.40M$418.70M$378.20M$382.80M$506.30M
Capital expenditure$75.80M$54.20M$36.30M$74.80M$55.00M$50.10M$44.60M$51.50M
Free cash flow$484.20M$393.60M$323.10M$442.60M$363.70M$328.10M$338.20M$454.80M
Investing cash flow-$543.30M-$190.80M-$159.00M-$322.00M-$163.30M-$1.38B-$106.00M-$291.20M
Financing cash flow-$27.20M-$271.10M-$369.20M-$897.00M$483.80M$163.80M$575.40M-$240.60M
Depreciation & amortization$282.00M$270.80M$270.00M$284.00M$283.60M$271.80M$254.40M$263.60M
Stock-based compensation$24.20M$24.60M$24.20M$24.10M$25.30M$21.20M$19.60M$21.10M
Dividends paid$45.80M$46.50M$46.90M$47.50M$47.50M$47.50M$47.80M$48.00M
Share buybacks$78.50M$250.70M$250.10M$250.00M$0$7.20M$229.80M$72.20M

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.